DONNA GIBSON: Open Payments
NPI 1730344458 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 34 payments from 17 companies in 2025. Trend: 2023 $1,219 · 2024 $665 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $172 |
| PFIZER INC. | 5 | $95 |
| Lilly USA, LLC | 4 | $82 |
| BeOne Medicines USA, Inc. | 2 | $42 |
| ARRAY BIOPHARMA INC | 2 | $41 |
| ABBVIE INC. | 2 | $38 |
| BeiGene USA, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| Incyte Corporation | 1 | $28 |
Products named: ERLEADA, VERZENIO, TECVAYLI, TEVIMBRA, ELREXFIO, BRAFTOVI, JEMPERLI, JAKAFI.
Industry payments across NC — which companies pay providers there.
